H-TYR-GLY-SER-LEU-PRO-GLN-LYS-ALA-GLN-ARG-PRO-GLN-ASP-GLU-ASN-OH;H-TYR-GLY-SER-LEU-PRO-GLN-LYS-SER-GLN-ARG-SER-GLN-ASP-GLU-ASN-OH;(DES-GLY77,DES-HIS78)-MYELIN BASIC PROTEIN (68-84) (BOVINE);(DES-GLY77,DES-HIS78)-MYELIN BASIC PROTEIN (68-84) (GUINEA PIG);DES-GLY77, DES-HIS78-MYELIN BASIC PROTEIN FRAGMENT 68-84 BOVINE;DES-[GLY77,HIS78] MYELIN BASIC PROTEIN (68-84), BOVINE;DES[GLY77,HIS78]-MYELIN BASIC PROTEIN, FRAGMENT 68-64;DES[GLY77, HIS78]-SER75,80-MYELIN BASIC PROTEIN BOVINE FRAGMENT 68-84
Myelin Basic Protein (MBP) fragment (68-82), guinea pig, is used as an antigen to induce Experimental Autoimmune Encephalomyelitis (EAE), a model for studying multiple sclerosis; it activates CD4+ and CD8+ T-lymphocytes in vitro, with a statistically significant increase in activated T-cells observed in whole blood assays; in vivo, it is used to study EAE induction, neurological deficit progression, and therapeutic interventions such as bee venom acupuncture (BVA), which demonstrates dose-dependent attenuation of EAE symptoms and weight loss in immunized rats.